Among those 15 patients, 9 carried the JAK2V617F mutation (3 PV, 3 ET, 3 PMF), 5 had a CALR mutation (4 ET, 1 PMF) and 1 was an MPL-mutated ET. This evidence concerns the gene CALR and essential thrombocythemia.